About University of Michigan Comprehensive Cancer Center Clinical Trials Office
Clinical Trials at University of Michigan Comprehensive Cancer Center Clinical Trials Office
During the past decade, University of Michigan Comprehensive Cancer Center Clinical Trials Office conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Comprehensive Cancer Center Clinical Trials Office"
#1 collaborator was "Indiana University School of Medicine" with 2 trials as a collaborator, "National Institute of Environmental Health Sciences (NIEHS)" with 1 trials as a collaborator and "Office of Research on Women's Health (ORWH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at University of Michigan Comprehensive Cancer Center Clinical Trials Office
According to Clinical.Site data, the most researched conditions in "University of Michigan Comprehensive Cancer Center Clinical Trials Office" are
"Breast Cancer" (3 trials), "Acute Myeloid Leukemia" (1 trials), "Adult Solid Tumor" (1 trials), "Cholangiocarcinoma" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "University of Michigan Comprehensive Cancer Center Clinical Trials Office" in a lesser frequency.
Clinical Trials Intervention Types at University of Michigan Comprehensive Cancer Center Clinical Trials Office
Most popular intervention types in "University of Michigan Comprehensive Cancer Center Clinical Trials Office" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Cytarabine" (1 trials), "Daunorubicin" (1 trials), "Decitabine" (1 trials), "Entrectinib" (1 trials) and "Low dose ARA-C (LDAC)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Michigan Comprehensive Cancer Center Clinical Trials Office
The vast majority of trials in "University of Michigan Comprehensive Cancer Center Clinical Trials Office" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at University of Michigan Comprehensive Cancer Center Clinical Trials Office
Currently, there are NaN active trials in "University of Michigan Comprehensive Cancer Center Clinical Trials Office".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University of Michigan Comprehensive Cancer Center Clinical Trials Office,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Michigan Comprehensive Cancer Center Clinical Trials Office, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".